Staurosporine ≥98%
Lieferant: ICN Biomedicals
0219140091
0219140080
0219140090
ICNA0219140091EA
1160
CHF
ICNA0219140091
ICNA0219140080
ICNA0219140090
Staurosporine ≥98%
Staurosporine
Staurosporine is provided in a lyophilised form. It may be reconstituted by dissolving the lyophilised reagent in DMSO (5 mg/ml - clear, colourless solution), DMF, ethyl acetate (5 mg/ml - clear colourless solution) or methanol. Stock solutions should be further diluted with aqueous buffers just prior to use. Stability depends upon the quality of solvent used. The compound should be stored at −20 °C in the dark.
Potent inhibitor of phospholipid/calcium-dependent protein kinase. Inhibits the upregulation of VEGF expression in tumor cells.
Formel:
C₂₈H₂₆N₄O₃ |
MDL Number:
MFCD18252446 CAS-Nummer: 62996-74-1 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...